ÂÜÀòÂÒÂ×

Martin Schuchardt serves as the Executive Director at FIECON since May 2021, a role that encompasses CEO responsibilities while leading a team of 30 professionals across various service areas, including Market Access strategy, HEOR, and HTA submission. Martin also holds the position of Global Pricing and Market Access Director at FIECON, focusing on actionable pricing and reimbursement strategies. In addition, Martin lectures at the Biotechnology Business Institute, educating future professionals on the drug discovery process. Prior to these roles, Martin served as Global Market Access Lead at Almirall, Manager of Consulting Services at IQVIA, and held consulting roles at Batten & Company and Alcimed. Academic qualifications include a Master’s degree in Science and Business Management from Utrecht University and a Bachelor’s degree in Molecular Biology from the University of Dundee.